Abstract
Continuous human malignant hematopoietic (MH) cell lines have become invaluable tools for hematological diagnosis and research. Over the last 35 years several hundred cell lines spanning almost the whole spectrum of hematopoietic cell lineages have been described. The cardinal features of MH cell lines are their monoclonal origin, arrest of differentiation, genetic alterations, and unlimited proliferation; the major advantages of cell lines are the unlimited supply of cell material and the infinite storability and recoverability at will of the cells. Categorization of cell lines usually follows the physiological stages of hematopoietic differentiation in the various cell lineages. For an adequate classification, a detailed and comparative characterization of both primary and cultured cells is absolutely necessary. New cell lines, in particular, must be adequately characterized. While clinical and cell culture data and immunological and cytogenetic features are the most important data, cell lines should be described in as much additional detail as possible allowing any singular features to be pointed out. In addition to detailed characterization, immortality of the culture, proof of neoplasticity, authentication of the true origin of the cells, scientific significance and availability of the cell line for other investigators are of paramount importance. In summary, MH cell lines have the potential to greatly facilitate diverse studies of normal and malignant hematopoiesis; to that end, these cell lines must be extensively characterized and adequately described.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A double-Flp-in method for stable overexpression of two genes
Scientific Reports Open Access 20 August 2020
-
Establishment and characterization of a novel childhood acute lymphoblastic leukemia cell line, HXEX-ALL1, with chromosome 9p and 17p deletions
Cancer Cell International Open Access 29 April 2019
-
Guidelines for the use of cell lines in biomedical research
British Journal of Cancer Open Access 12 August 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Drexler, H., Matsuo, Y. Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia 13, 835–842 (1999). https://doi.org/10.1038/sj.leu.2401428
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401428
Keywords
This article is cited by
-
A double-Flp-in method for stable overexpression of two genes
Scientific Reports (2020)
-
Establishment and characterization of a novel childhood acute lymphoblastic leukemia cell line, HXEX-ALL1, with chromosome 9p and 17p deletions
Cancer Cell International (2019)
-
Guidelines for the use of cell lines in biomedical research
British Journal of Cancer (2014)
-
Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma
International Journal of Hematology (2013)
-
STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma
Leukemia (2009)